Evercore ISI Upgrades Mettler-Toledo International (NYSE:MTD) to Outperform

Mettler-Toledo International (NYSE:MTD - Get Free Report) was upgraded by Evercore ISI from an "in-line" rating to an "outperform" rating in a research report issued on Thursday, Marketbeat.com reports. The firm currently has a $1,450.00 price target on the medical instruments supplier's stock, up from their prior price target of $1,375.00. Evercore ISI's price target indicates a potential upside of 18.78% from the stock's current price.

A number of other equities research analysts also recently weighed in on MTD. Wolfe Research began coverage on Mettler-Toledo International in a report on Friday, December 13th. They issued a "peer perform" rating on the stock. Wells Fargo & Company reduced their price objective on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an "equal weight" rating on the stock in a research note on Monday, November 11th. Robert W. Baird lowered their target price on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a "neutral" rating for the company in a research note on Monday, November 11th. Citigroup upgraded shares of Mettler-Toledo International from a "sell" rating to a "neutral" rating and raised their price target for the company from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Finally, Stifel Nicolaus lowered their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a "buy" rating for the company in a research report on Monday, November 11th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, Mettler-Toledo International presently has an average rating of "Hold" and a consensus target price of $1,351.25.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD traded down $2.90 during mid-day trading on Thursday, reaching $1,220.78. The company had a trading volume of 103,571 shares, compared to its average volume of 134,395. The firm has a market cap of $25.76 billion, a price-to-earnings ratio of 32.91, a PEG ratio of 4.21 and a beta of 1.13. The business's 50-day simple moving average is $1,258.07 and its 200 day simple moving average is $1,357.66. Mettler-Toledo International has a one year low of $1,115.64 and a one year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, beating the consensus estimate of $10.00 by $0.21. The firm had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. On average, sell-side analysts anticipate that Mettler-Toledo International will post 40.42 EPS for the current year.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the company's stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the sale, the director now owns 240 shares in the company, valued at approximately $314,820. The trade was a 24.05 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Gerry Keller sold 140 shares of the firm's stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total value of $175,572.60. Following the transaction, the insider now owns 6 shares of the company's stock, valued at $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company's stock.

Institutional Investors Weigh In On Mettler-Toledo International

Institutional investors have recently modified their holdings of the company. Rothschild Investment LLC bought a new stake in Mettler-Toledo International during the second quarter valued at $42,000. TD Asset Management Inc grew its stake in Mettler-Toledo International by 1.9% during the second quarter. TD Asset Management Inc now owns 157,247 shares of the medical instruments supplier's stock worth $219,767,000 after purchasing an additional 2,866 shares during the period. National Bank of Canada FI increased its holdings in Mettler-Toledo International by 14.7% in the second quarter. National Bank of Canada FI now owns 6,956 shares of the medical instruments supplier's stock worth $9,507,000 after purchasing an additional 894 shares in the last quarter. Kornitzer Capital Management Inc. KS lifted its stake in Mettler-Toledo International by 3.7% in the second quarter. Kornitzer Capital Management Inc. KS now owns 2,697 shares of the medical instruments supplier's stock valued at $3,769,000 after buying an additional 96 shares during the period. Finally, Torray Investment Partners LLC boosted its holdings in shares of Mettler-Toledo International by 8.5% during the 2nd quarter. Torray Investment Partners LLC now owns 1,351 shares of the medical instruments supplier's stock worth $1,888,000 after buying an additional 106 shares in the last quarter. 95.07% of the stock is owned by institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.